Patent ID: 7202213
Filing Date: 2007-04-10
Classification: C07C

Abstract:
1. A pharmaceutical composition comprising a glucagon like peptide-1 (GLP-1) derivative and a dual Peroxisome Proliferator-Activated Receptor-α/Peroxisome Proliferator Activated Receptor-γ (PPARα/PPAR-γ) activator wherein the dual PPAR-α/PPAR-γ activator is a compound of formula (I) wherein X is hydrogen or Y is hydrogen or Z is hydrogen, halogen, hydroxy or Q is O, S or NR Ar is arylene, heteroarylene or a divalent heterocyclic group each of which can be optionally substituted with one or more substituents selected from C R R R R n is an integer ranging from 0 to 3; and m is an integer ranging from 0 to 1; or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, or any tautomeric forms, stereoisomers, mixture of stereoisomers, racemic mixture, or polymorphs.